NCT03157167 2025-03-05
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Navidea Biopharmaceuticals
Phase 1 Completed
Clinical Trials
1 trialsPhase 1 × Sarcoma, Kaposi × technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran × Clear all